FIELD: medicine, pharmacy. SUBSTANCE: invention relates to a method of preparing hepatotropic conjugates that carry out the delivery of drugs in the liver and a pharmaceutical composition containing these conjugates. Antiviral drugs (for example, ara-AMP, aciclovir and others) are conjugated with a carrier taken among polyamino acids and, in part, with poly-L-lysine or poly-L-ornithine where the most part of amino-groups is not substituted with antiviral drugs but substituted with galactose molecules and these preparations are used for treatment of patients with hepatitis. EFFECT: decreased toxicity, absence of antibody formation after intramuscular administration. 15 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING SOLUBLE COVALENT CONJUGATES | 1994 |
|
RU2127606C1 |
METHOD FOR PRODUCTION OF POLYCATION-BASED BIOCONJUGATES USEFUL IN DELIVERY OF VARIOUS KINDS OF ACTIVE SUBSTANCES INTO ORGANISM | 2000 |
|
RU2250782C2 |
HYBRID PROTEINS AND PROTEIN CONJUGATES BASED ON HEAT SHOCK PROTEIN-70 (HSP70) AND METHODS FOR USE THEREOF (VERSIONS) | 2012 |
|
RU2685867C2 |
BIOLOGICALLY ACTIVE DERIVATIVES OF PEPTIDE VAPEEHPTLLTEAPLNPK | 2005 |
|
RU2377249C2 |
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY MEANS OF GLYCOENGINEERING | 2014 |
|
RU2711935C2 |
LIGAND COMPOUNDS, CONJUGATES AND USE THEREOF | 2021 |
|
RU2819894C1 |
INTERFERON CONJUGATES | 1997 |
|
RU2180595C2 |
ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY | 2009 |
|
RU2531591C2 |
COMPOSITION OF DELIVERY SYSTEM BASED ON CONJUGATE FOR RNA-INTERFERENCE POLYNUCLEOTIDE DELIVERY TO LIVER CELL AND PROCESS FOR ITS PREPARATION | 2011 |
|
RU2623160C9 |
ANTI-TROP2 ANTIBODY-DRUG CONJUGATE | 2014 |
|
RU2705367C2 |
Authors
Dates
1999-10-27—Published
1994-05-24—Filed